Search results
3 Things You Need to Know If You Buy Novavax Today
The Motley Fool via AOL· 2 days agoThat's why Sanofi's agreement to co-commercialize Novavax's vaccine as of next year is such positive news for the smaller company. In addition, Sanofi...
Free COVID-19 vaccines could be a thing of the past as federal program is set to expire early
Chicago Sun-Times· 1 day agoWhen COVID-19 vaccines entered the commercial market, the federal government introduced a program to...
Could current COVID vaccines protect against future outbreaks? New study offers hope
Orange County Register· 23 hours agoA group of researchers had the future in mind when they asked if current COVID-19 vaccines and...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA TODAY via Yahoo News· 2 days agoSince Bridge Access launched on Sept. 13, 2023, it has provided more than 1.4 million free COVID-19 ...
This Stock Just More Than Doubled in 1 Day: Is It a Buy? | The Motley Fool
The Motley Fool· 5 days agoThe biotech has come a long way since its not-so-successful attempt at dominating the coronavirus ...
The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom
InvestorPlace· 1 day agoNovavax (NASDAQ:NVAX) stock was among the laggards in the race for the vaccine against COVID-19....
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 2 days agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoAccording to a report from NBC News, experts predict a small rise in COVID-19 cases as a newly...
Is Novavax Stock a Buy?
The Motley Fool via AOL· 6 days agoRival Moderna announced earlier this year that it would be pausing plans to build a plant in Kenya for vaccine development due to a drop in demand for its COVID< ...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 5 days agoIt is entitled to up to $700 million related to various clinical and regulatory milestones for ...
